<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" version="2.0">
  <channel>
    <title><![CDATA[Genome Based Drug Discovery]]></title>
    <link>https://www.leadingmarketresearch.com/pharmaceuticals-biotechnology/biotechnology/genome-based-drug-discovery</link>
    <description><![CDATA[Genome Based Drug Discovery]]></description>
    <pubDate>Sun, 14 Jun 2026 18:29:39 +0000</pubDate>
    <generator>Zend_Feed</generator>
    <docs>http://blogs.law.harvard.edu/tech/rss</docs>
    <item>
      <title><![CDATA[Genome-Based Drug Industry Forecasts - China Focus]]></title>
      <link>https://www.leadingmarketresearch.com/genome-based-drug-industry-forecasts-china-focus</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;">This study focuses on China’s Genome-Based Drug industry forecasts. In the two past decades, the industry has been growing at a fast pace.   The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world’s fastest growing market for the consumptions of goods and services.  The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. Rapid consolidation between medium and large players is anticipated since the Chinese government has been encouraging industry consolidation with an effort to regulate the industry and to improve competitiveness in the world market. 

Although China has enjoyed the benefits of an expanding market for production and distribution, the industry is suffering from minimal innovati...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-226327"><span class="price">$1,800.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Fri, 03 Jun 2022 13:56:52 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Genome-Based Drug Companies in China]]></title>
      <link>https://www.leadingmarketresearch.com/genome-based-drug-companies-in-china</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;">This study focuses on China’s Genome-Based Drug industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace.   The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world’s fastest growing market for the consumptions of goods and services.  The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. Rapid consolidation between medium and large players is anticipated since the Chinese government has been encouraging industry consolidation with an effort to regulate the industry and to improve competitiveness in the world market. 

Although China has enjoyed the benefits of an expanding market for production and distribution, the industry is sufferin...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-226385"><span class="price">$1,800.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Fri, 03 Jun 2022 13:56:52 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Genome Editing/Genome Engineering Market Size, Share &amp; Trends Analysis By Product &amp; Service, By Application, By Technology, By End-Users, Regional Outlook, Competitive Strategies and Segment Forecasts to 2030]]></title>
      <link>https://www.leadingmarketresearch.com/genome-editing-genome-engineering-market-size-share-and-trends-analysis</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;">Global Genome Editing/Genome Engineering Market is projected to be worth USD 25.3 billion by 2030

According to SPER Market Research, the Genome Editing/Genome Engineering Market is estimated to reach USD 25.3 billion by 2030 with a CAGR of 19.5%. Academies & government research centre used genome engineering before, now it is diversified into clinical & diagnostic fields too, this leads to the escalation of the market.

Impact of COVID-19 on the Genome Editing/Genome Engineering Market 
The outbreak of COVID-19 has boosted the investment of pharmaceutical companies and biopharmaceutical companies, and genomic market player in research & development and in vaccine.

Scope of the report:
Market size available for years  
2019-2030

Base year considered  
2021

Forecast period  
2022-2030

Segments covered 
By Product & Service, By Application, By Technology, By End Users, By Region

Geographies covered  
North America, Europe, Asia Pacific, Latin America, Middle East, Africa

Companies Covered 
Agilent Technologies, Beam Therapeutics, Bluebird Bio, Caribou Biosciences., Cellectis S.A,...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-225136"><span class="price">$4,250.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Wed, 11 May 2022 11:50:02 +0000</pubDate>
    </item>
  </channel>
</rss>
